This review comes from a themed issue on Diet, behavior and brain function
Edited by Dana M Small and Susanne E la Fleur In peripheral tissues insulin activates signaling cascades to facilitate glucose uptake from the blood into tissues like liver, muscle and fat. Although insulin appears to play a minor role in the regulation of glucose uptake in the central nervous system (CNS), insulin is known to play a major role in regulating synaptic plasticity in brain regions like the hippocampus. The concept that insulin regulates hippocampal neuroplasticity is further supported from animal models of type 2 diabetes (T2DM) and Alzheimer's disease (AD). The goal of this review is to provide an overview of these studies, as well as the studies that have examined whether deficits in hippocampal insulin signaling are amenable to intervention strategies.
Introduction Insulin signaling in the CNS
Insulin is synthesized by pancreatic b cells and is released into circulation in response to increases in plasma glucose levels. Once released into circulation, insulin binds to and activates insulin receptors to promote glucose uptake and utilization in peripheral tissues such as liver, muscle and fat. Although the central nervous system was once viewed as an insulin-insensitive organ, studies by Woods and coworkers demonstrated that intracerebroventricular administration of insulin suppressed food intake and body weight in a dosedependent manner [1] . These seminal observations shed light on a role for insulin in the CNS and ultimately lead to a greater understanding of the role of hypothalamic peptide systems in the regulation of food intake, body weight and metabolism [2, 3] . Beyond the hypothalamus, it is clear that the actions of insulin extend into other regions of the CNS including the hippocampus. Insulin receptors are expressed in the hippocampus [4, 5] and activate similar signaling cascades as have been identified in peripheral tissues [6] . In this regard, insulin crosses the blood-brain barrier (BBB) by a carrier facilitated process [7] and binds to insulin receptors expressed in the CNS, including the hippocampus. The insulin receptor is a heterotetrameric protein complex consisting of 2 a subunits that provide the insulin binding site and the membrane spanning b subunits that stimulate autophosphorylation of the b subunits. This initiates several signaling cascades, including the PI3-kinase/Akt pathway and MAPK/Erk signaling pathway (see Figure 1) . It is important to note that these insulin-stimulated signaling cascades exhibit significant cross-talk and also that these signaling pathways are not the exclusive domain of insulin receptor activation. For example, leptin also facilitates hippocampal synaptic plasticity through activation of these pathways [8] . Conversely, hippocampal insulin resistance (i.e. 'stop signs' in insulin signaling; Figure 1 ) contributes to neuroplasticity deficits in T2DM, obesity and AD. The sections below will describe the causes and consequences of this biphasic relationship between hippocampal insulin signaling and neuroplasticity, with a particular emphasis on how hippocampal insulin resistance contributes to the structural, functional and behavioral deficits observed in T2DM, obesity and AD.
Insulin, cognition and behavior
Clinical and preclinical studies support the hypothesis that insulin is a crucial regulator of structural and functional plasticity in the hippocampus, including cognitive function. 
